Furthermore, we demonstrated that pharmacological inhibition of choroidal MC degranulation effectively attenuated myopia progression and suppressed scleral remodeling by preventing the downregulation of COL1A1 and the upregulation of matrix metallopeptidase 2 (MMP-2) (Supplementary Fig. S6). Here, MMP2 is linked to myopia.